LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

Search

Smith & Nephew PLC ADR

Закрыт

36.23 1.51

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

35.7

Макс.

36.29

Ключевые показатели

By Trading Economics

Доход

296M

Продажи

3B

P/E

Средняя по отрасли

32.595

110.024

Дивидендная доходность

2.11

Рентабельность продаж

9.895

Сотрудники

17,000

EBITDA

723M

Рекомендации

By TipRanks

Рекомендации

Нейтрально

Прогноз на 12 месяцев

-4.75% downside

Дивиденды

By Dow Jones

Дивидендная доходность

Средняя по отрасли

2.11%

2.26%

Рыночная статистика

By TradingEconomics

Рыночная капитализация

15B

Предыдущая цена открытия

34.72

Предыдущая цена закрытия

36.23

Техническая оценка

By Trading Central

Уверенность

Bullish Evidence

Smith & Nephew PLC ADR График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

18 февр. 2026 г., 22:31 UTC

Отчет

Brambles Raises Dividend, Cash-Flow Guidance as 1st Half Profit Jumps -- Update

18 февр. 2026 г., 22:18 UTC

Отчет

Wal-Mart de Mexico 4Q Profit Falls, Hit by Higher Taxes

18 февр. 2026 г., 22:11 UTC

Отчет

Wesfarmers Boosts Dividend After 1st Half Profit Rises -- Update

18 февр. 2026 г., 21:52 UTC

Отчет

Telstra Boosts Dividend as First-Half Earnings Rise 5.5% -- Update

18 февр. 2026 г., 23:56 UTC

Обсуждения рынка

Santos's Review of Domestic Assets Could Lead to Simpler Portfolio -- Market Talk

18 февр. 2026 г., 23:46 UTC

Обсуждения рынка

Global Forex and Fixed Income Roundup: Market Talk

18 февр. 2026 г., 23:46 UTC

Обсуждения рынка

Nikkei May Rise After U.S. Tech Stock Gains -- Market Talk

18 февр. 2026 г., 23:34 UTC

Обсуждения рынка
Отчет

Brambles' Cost Control Stands Out to Bull -- Market Talk

18 февр. 2026 г., 23:33 UTC

Обсуждения рынка

Gold Edges Higher Amid Growing Risks of U.S.-Iran Conflict -- Market Talk

18 февр. 2026 г., 23:32 UTC

Обсуждения рынка

Australia Jobs Data Will Likely Support May Hike Assumptions -- Market Talk

18 февр. 2026 г., 22:45 UTC

Отчет

DoorDash Stock Rebounds. Earnings and Revenue Both Fall Short. -- Barrons.com

18 февр. 2026 г., 22:44 UTC

Обсуждения рынка

Investors Eyeing Nvidia's Revenue Visibility Ahead of 4Q Print -- Market Talk

18 февр. 2026 г., 22:37 UTC

Отчет

Nutrien 4Q EPS $1.18 >NTR.T

18 февр. 2026 г., 22:37 UTC

Отчет

Nutrien 4Q Sales $5.34B >NTR.T

18 февр. 2026 г., 22:35 UTC

Отчет

Pan American Silver 4Q EPS $1.07 >PAAS

18 февр. 2026 г., 22:35 UTC

Отчет

Pan American Silver 4Q Rev $1.18B >PAAS

18 февр. 2026 г., 22:30 UTC

Отчет

Kinross Gold Raises Quarterly Dividend to 4c Vs. 3.5c >K.T

18 февр. 2026 г., 22:29 UTC

Отчет

Kinross Gold 4Q EPS 75c >K.T

18 февр. 2026 г., 22:22 UTC

Отчет

Coeur Mining: Full-Yr 2026 Production Is Expected to Be 55,000 - 65,000 Ounces of Gold and 5.5M - 6.3M Ounces of Silver >CDE

18 февр. 2026 г., 22:22 UTC

Обсуждения рынка

Nvidia 4Q Earnings Coming Amid China Export Battle -- Market Talk

18 февр. 2026 г., 22:16 UTC

Отчет

Brambles Raises Dividend, Cash-Flow Guidance as 1H Profit Jumps -- Update

18 февр. 2026 г., 22:05 UTC

Отчет

Pan American Silver Reports Record Fourth Quarter And Full Year 2025 Financial Results; Record Cash Flow From Operations Of $554 Million In The Fourth Quarter; Dividend Increased By 29% >PAAS

18 февр. 2026 г., 22:03 UTC

Отчет

Kaiser Aluminum Expects to Improve Conversion Rev by 5% to 10% and Adj EBITDA by 5% to 15% for FY26 >KALU

18 февр. 2026 г., 22:02 UTC

Отчет

Kaiser Aluminum 4Q Adj EPS $1.53 >KALU

18 февр. 2026 г., 22:02 UTC

Отчет

Kaiser Aluminum 4Q Sales $929M >KALU

18 февр. 2026 г., 22:02 UTC

Отчет

Kaiser Aluminum 4Q EPS $1.68 >KALU

18 февр. 2026 г., 22:00 UTC

Отчет

Kinross Gold 4Q Adj EPS 67c >KGC

18 февр. 2026 г., 22:00 UTC

Отчет

Kinross Gold 4Q Sales $2.02B >KGC

18 февр. 2026 г., 21:56 UTC

Отчет

Wesfarmers Boosts Dividend After 1H Profit Rises -- Update

18 февр. 2026 г., 21:50 UTC

Обсуждения рынка

Tech, Media & Telecom Roundup: Market Talk

Сравнение c конкурентами

Изменение цены

Smith & Nephew PLC ADR Прогноз

Целевая цена

By TipRanks

-4.75% падение

Прогноз на 12 месяцев

Средняя 34.46 USD  -4.75%

Максимум 34.91 USD

Минимум 34 USD

Основано на мнении 2 аналитиков Wall Street, спрогнозировавших целевые цены для Smith & Nephew PLC ADR на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Нейтрально

2 ratings

0

Покупка

2

Удержание

0

Продажа

Техническая оценка

By Trading Central

26.64 / 28.37Поддержка и Сопротивление

Краткосрочная

Bullish Evidence

Среднесрочная

Bullish Evidence

Долгосрочная

Bullish Evidence

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Smith & Nephew PLC ADR

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
help-icon Live chat